Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1253 Views
-
Last post by frodo
-
- 0 Replies
- 922 Views
-
Last post by frodo
-
- 0 Replies
- 2236 Views
-
Last post by NHE
-
- 0 Replies
- 1234 Views
-
Last post by frodo
-
- 0 Replies
- 1183 Views
-
Last post by frodo
-
- 0 Replies
- 1142 Views
-
Last post by frodo
-
- 0 Replies
- 1371 Views
-
Last post by NHE
-
- 0 Replies
- 410 Views
-
Last post by NHE
-
- 1 Replies
- 2836 Views
-
Last post by Tif